Article Text

PDF
Histopathological reporting of paediatric cutaneous vascular anomalies in relation to proposed multidisciplinary classification system
  1. M Al-Adnani,
  2. S Williams,
  3. D Rampling,
  4. M Ashworth,
  5. M Malone,
  6. N J Sebire
  1. Department of Paediatric Histopathology, Camelia Botnar Laboratories, Great Ormond Street Hospital, London, UK
  1. Correspondence to:
 Dr N J Sebire
 Department of Paediatric Histopathology, Camelia Botnar Laboratories, Great Ormond Street Hospital, London WC1N 3JH, UK;sebirN{at}gosh.nhs.uk

Abstract

Background: The terminology applied to vascular anomalies has been variable in previously published literature making interpretation suboptimal. The International Society for the Study of Vascular Anomalies (ISSVA) has proposed a revised classification based on clinical features and histopathological findings. This classification is increasingly being accepted as clinically useful and a platform for future studies.

Aims: To examine the extent to which the ISSVA classification can be practically applied to diagnostic histopathological specimens.

Methods: Cutaneous vascular lesions received in a single paediatric pathology unit during a 2-year period (2004–5) were reviewed, including glucose transporter protein 1 (GLUT1) immunostaining where required, and lesions were reclassified according to the ISSVA classification.

Results: 144 specimens were identified. Appropriate full clinical information was provided in only 17% of cases at submission. Infantile haemangiomas comprised 46% of cases, 18% of which were regressive type, initially inaccurately identified as vascular malformations before GLUT1 immunostaining. 30% of lymphatic malformations and all lymphovenous malformations were previously classified as vascular malformations, not otherwise specified.

Conclusions: The ISSVA classification of vascular anomalies provides a useful framework for histopathologists to classify vascular anomalies. However, meaningful and appropriate use of such a system is dependent on the adequacy of clinical information provided and routine use of immunohistochemical markers.

  • GLUT1, glucose transporter protein 1
  • ISSVA, International Society for the Study of Vascular Anomalies

Statistics from Altmetric.com

Footnotes

  • Published Online First 2 June 2006

  • Competing interests: None declared.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.